Want to join the conversation?
$EW now sees 2016 sales to be at high end of its prior $2.7-3Bil range based on strong 1H results, expected 3Q approval of intermediate risk in the U.S., and momentum of therapy adoption globally. $EW raised FY16 adjusted EPS outlook to $2.78-2.88 from prior range of $2.67-2.77. For 3Q16, $EW sees sales of $720-760MM and adjusted EPS of $0.62-0.68.
The latest earnings report by $VZ shows how it is losing customers despite offering the unlimited data plans, a record for the company.
$BEBE is closing down all its stores by the end of May.
$WFC agreed to hike its payout in a class-action settlement over unauthorized accounts by $32 million to $142 million for its retail sales practices. The settlement will now include customers who were impacted as early as May 2002.